MYEF2: an immune infiltration-related prognostic factor in IDH-wild-type glioblastoma-Reference-Cited by-同舟云学术

MYEF2: an immune infiltration-related prognostic factor in IDH-wild-type glioblastoma

Published:2023-08-08 Issue: Volume: Page:
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Zhang Yunxiao¹,Wen Yunyu¹,Nie Jing¹,Wang Tong²,Wang Gang¹,Gao Qiaoping³,Cao Yongfu⁴,Wang Hai¹,Qi Songtao¹,Xie Sidi¹

Affiliation:

1. Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, PR China

2. Department of Neurosurgery, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang 621000, Sichuan, PR China

3. Department of Medical Quality Management, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, PR China

4. Neurosurgery, Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, Guangdong, PR China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference33 articles.

1. High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.;Pentheroudakis;Ann Oncol,2014

2. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.;Ellison;Neuro Oncol,2021

3. cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".;Weller;Acta Neuropathol,2018

4. Glioblastoma: exosome and microRNA as novel diagnosis biomarkers.;Mirzaei;Cancer Gene Ther,2016

5. MGMT gene silencing and benefit from temozolomide in glioblastoma.;Mirimanoff;N Engl J Med,2005

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glioblastoma: A molecular insight into current discoveries and treatment directions;Medical Journal of Cell Biology;2024-07-01